Biontech Se ADR (BNTX)
94.40 x 1 100.00 x 1
Post-market by (Cboe BZX)
98.76 +0.51 (+0.52%) 04/17/25 [NASDAQ]
94.40 x 1 100.00 x 1
Post-market 98.76 unch (unch) 16:07 ET
for Thu, Apr 17th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -733,339 | 1,283,716 | 13,648,440 | 17,801,400 | -166,550 |
| Depreciation Amortization | 322,466 | 198,494 | 129,909 | 88,969 | 44,257 |
| Accounts receivable | 419,530 | 5,816,280 | 4,604,126 | -13,970,160 | -283,160 |
| Accounts payable and accrued liabilities | 820,665 | 128,686 | 90,294 | 1,793,698 | 233,695 |
| Other Working Capital | 1,320,811 | 6,033,606 | 4,760,691 | -12,695,140 | -106,345 |
| Other Operating Activity | -1,925,380 | -7,647,315 | -8,928,309 | 8,033,837 | 262,711 |
| Operating Cash Flow | $224,752 | $5,813,466 | $14,305,150 | $1,052,604 | $-15,391 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | -443,899 | N/A |
| PPE Investments | -308,723 | -270,683 | -346,213 | -146,823 | -74,012 |
| Net Acquisitions | N/A | -364,627 | N/A | -24,609 | -69,273 |
| Purchase Of Investment | -13,385,900 | -7,715,067 | -50,362 | -23,071 | N/A |
| Sale Of Investment | 11,621,970 | 1,316,401 | 395,311 | N/A | N/A |
| Purchase Sale Intangibles | -179,412 | -492,879 | -35,928 | -31,352 | -22,176 |
| Other Investing Activity | -179,413 | -492,879 | -35,928 | -31,352 | -22,176 |
| Investing Cash Flow | $-2,252,066 | $-7,526,855 | $-37,192 | $-669,753 | $-165,460 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 325 | 843 | N/A | 178,230 |
| Debt Repayment | -2,489 | -108 | -19,808 | -62,231 | -1,789 |
| Common Stock Issued | N/A | N/A | 116,423 | 190,361 | 860,160 |
| Common Stock Repurchased | N/A | -799,279 | -1,039,271 | N/A | N/A |
| Dividend Paid | N/A | N/A | -510,259 | N/A | N/A |
| Other Financing Activity | -47,180 | -43,617 | -43,304 | -16,682 | -14,557 |
| Financing Cash Flow | $-49,668 | $-842,679 | $-1,495,375 | $111,448 | $1,022,044 |
| Exchange Rate Effect | 16,015 | -15,693 | 62,795 | 76,547 | -51,795 |
| Beginning Cash Position | 12,621,290 | 15,017,020 | 1,783,429 | 1,431,788 | 593,024 |
| End Cash Position | 10,563,350 | 12,623,620 | 14,618,810 | 2,002,633 | 1,382,422 |
| Net Cash Flow | $-2,057,938 | $-2,393,398 | $12,835,380 | $570,846 | $789,398 |
| Free Cash Flow | |||||
| Operating Cash Flow | 224,752 | 5,813,466 | 14,305,150 | 1,052,604 | -15,391 |
| Capital Expenditure | -310,022 | -269,926 | -346,845 | -150,845 | -75,430 |
| Free Cash Flow | -85,269 | 5,543,540 | 13,958,305 | 901,759 | -90,821 |